16:01 EDT Acelyrin Inc trading halted, news pending
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SLRN:
- Acelyrin (NASDAQ: SLRN) Plummets on Disappointing HS Trial Results
- ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
- ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
- Acelyrin price target raised to $39 from $29 at Morgan Stanley
- Acelyrin initiated with a Buy at H.C. Wainwright